These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9268756

  • 1. Calcipotriol in psoriasis vulgaris: a controlled trial comparing betamethasone dipropionate + salicylic acid.
    Crosti C, Finzi AF, Mian E, Scarpa C.
    Int J Dermatol; 1997 Jul; 36(7):537-9. PubMed ID: 9268756
    [No Abstract] [Full Text] [Related]

  • 2. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid.
    Tosti A, Piraccini BM, Cameli N, Kokely F, Plozzer C, Cannata GE, Benelli C.
    Br J Dermatol; 1998 Oct; 139(4):655-9. PubMed ID: 9892909
    [Abstract] [Full Text] [Related]

  • 3. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
    Scarpa C.
    Acta Derm Venereol Suppl (Stockh); 1994 Oct; 186():47. PubMed ID: 8073835
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y.
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [Abstract] [Full Text] [Related]

  • 6. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N, Miracapillo A, Coviello C, Loconsole F, Bellino M, Vena GA.
    Clin Drug Investig; 2006 Jun; 26(4):227-33. PubMed ID: 17163256
    [Abstract] [Full Text] [Related]

  • 7. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alternative treatment with calcipotriol plus betamethasone dipropionate gel in psoriasis vulgaris using a short-contact approach.
    Queille-Roussel C, Clonier F, Olesen M.
    Br J Dermatol; 2014 Dec; 171(6):1596-8. PubMed ID: 25109395
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
    Liu L, Zhang C, Wang J, Chen K, Ding Y, Yan G, Lu Q, Li W, Fang H, Cheng H, Zhang J, He Y, Zhu W, Lu Y, Huang J, Pan W, Li M, Cao S, Li S, Han X, He L, Chen Y, Zheng M.
    Eur J Dermatol; 2020 Oct 01; 30(5):580-590. PubMed ID: 33052103
    [Abstract] [Full Text] [Related]

  • 11. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 Oct 01; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
    Reich K, Zschocke I, Bachelez H, de Jong EM, Gisondi P, Puig L, Warren RB, Mrowietz U, TTOP study group.
    J Eur Acad Dermatol Venereol; 2015 Jun 01; 29(6):1156-63. PubMed ID: 25346093
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S.
    Br J Dermatol; 2009 Jul 01; 161(1):159-66. PubMed ID: 19416259
    [Abstract] [Full Text] [Related]

  • 14. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
    Tzung TY, Chen CY, Yang CY, Lo PY, Chen YH.
    Acta Derm Venereol; 2008 Jul 01; 88(3):279-80. PubMed ID: 18480933
    [No Abstract] [Full Text] [Related]

  • 15. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH.
    J Drugs Dermatol; 2011 Aug 01; 10(8):878-82. PubMed ID: 21818509
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC.
    Br J Dermatol; 2004 Sep 01; 151(3):663-8. PubMed ID: 15377355
    [Abstract] [Full Text] [Related]

  • 18. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM.
    J Dermatolog Treat; 2007 Sep 01; 18(1):32-9. PubMed ID: 17365265
    [Abstract] [Full Text] [Related]

  • 19. Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.
    Charakida A, Dadzie O, Teixeira F, Charakida M, Evangelou G, Chu AC.
    Expert Opin Pharmacother; 2006 Apr 01; 7(5):597-606. PubMed ID: 16553575
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.